(Adds details thoroughout) Sept 25 (Reuters) – The US Food and Drug Administration has approved Mirum Pharmaceuticals' drug to treat a rare bone disorder, the regulator said on Friday. The drug,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Adds closing prices) * USDA projects US corn, soy harvests and end-of-season stocks below trade…
VIDEO SHOWS: CANADIAN ULTRARUNNER STEPHANIE CASE, ATTEMPTING AND BECOMING THE FIRST WOMAN TO COMPLETE 100…
* Colombia October inflation edges up to 6.3% * Colombia third-quarter economic growth seen cooling…
By Chris Prentice NEW YORK, Nov 10 (Reuters) - The US Securities and Exchange Commission…
By Wen-Yee Lee, Andrew Silver and Laurie Chen TAIPEI/SHANGHAI/BEIJING, Nov 10 (Reuters) - Alice Huang…
One thing about being a defending national champion: You're going to get everyone's best shot,…